Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...

Last week, after Musk saw a huge drop in a single day (not unrelated to the market-wide fall caused by Trump’s tariffs and ...

The esteemed initiative equips early-career scientists with leadership training and networking opportunities COLUMBUS, Ohio, ...

According to an attorney for a detained Venezuelan asylum-seeker, her client’s deportation was justified because he had a ...

Graphic design students at University of Wisconsin-Stout collaborate with Epic Systems to improve patient and healthcare ...

Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by ...

A French researcher was denied entry to the U.S. over text messages on his phone that were critical of President Donald Trump ...

SEALSQ filed its Condensed Consolidated Financial Statements in the Form 20-F for the full year period ended December 31, 2024, with the U.S. Securities and Exchange Commission on March 20, 2025. The ...

Dose expansion in Phase 1 CARDINAL trial of TERN-701 for chronic myeloid leukemia (CML) expected to initiate in 2Q25 with additional safety and ...

U.S. private equity firm Bain Capital will subscribe to Manappuram's shares and warrants at 236 rupees apiece, at a 9% ...

IceCure Medical Ltd. ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor ...

An NBC News analysis found hundreds of lawsuits over five years alleging that embryos were lost, destroyed or swapped by ...